semaglutide off patent Generic injectable could cost as little as $28 per person-year after the initial expired in April 2026 — a fraction of current branded prices — and be available in about Novo's Ozempic Patent Expires Jan.

HSA and FSA accounts are accepted, making treatment accessible and tax-advantaged

GLP-1 receptor agonists like Wegovy and Ozempic have made a significant impact in weight loss and metabolic health, helping many individuals achieve their goals

5,6 In line with previous cardiovascular outcome studies, HARMONY Outcomes assessed as its primary outcome the three-point Major Adverse Cardiovascular Events (3-point MACE: cardiovascular death, non-fatal myocardial infarction and non-fatal stroke)

Muscle loss also promotes further dysfunction of the glucose uptake mechanisms, promoting the effects of diabetes and typically making it much worse, notes Dana McCurdy, PhD

Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone produced primarily by specialised cells in the distal small intestine (ileum) and colon, called L-cells

Reviewed by the Healthylife health experts August 2025